Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimers disease

Alzheimers disease (AD) is a chronic neurodegenerative disorder that accounts for about 60% of all diagnosed cases of dementia worldwide. Although there are currently several drugs marketed for its treatment, none are capable of slowing down or stopping the progression of AD. The role of the blood-b...

ver descrição completa

Detalhes bibliográficos
Autor principal: Del Amo, Laura (author)
Outros Autores: Cano, Amanda (author), Ettcheto, Miren (author), Souto, Eliana B. (author), Espina, Marta (author), Camins, Antoni (author), García, Maria Luísa (author), Sánchez-López, Elena (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
functionalized PLGA nanoparticles
brain delivery
blood-brain barrier
Alzheimers disease
Alzheimer’
s disease
Alzheimer&#8217
Science & Technology
Texto completo:http://hdl.handle.net/1822/72610
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/72610

Texto Completo

http://hdl.handle.net/1822/72610

Registros relacionados